Co-Administration of Lipid Nanoparticles and Sub-Unit Vaccine Antigens Is Required for Increase in Antigen-Specific Immune Responses in Mice
A vast body of evidence suggests that nanoparticles function as potent immune-modulatory agents. We have previously shown that Merck proprietary Lipid NanoParticles (LNPs) markedly boost B-cell and T-cell responses to sub-unit vaccine antigens in mice. To further evaluate the specifics of vaccine de...
Main Authors: | Elizabeth A. Thoryk, Gokul Swaminathan, Steven Meschino, Kara S. Cox, Marian Gindy, Danilo R. Casimiro, Andrew J. Bett |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/4/4/47 |
Similar Items
-
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
by: Sakshi Bajoria, et al.
Published: (2022-11-01) -
Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform
by: Lisa D. MacDonald, et al.
Published: (2018-01-01) -
<i>Leptospira</i> Lipid A Is a Potent Adjuvant That Induces Sterilizing Immunity against Leptospirosis
by: Vivek P. Varma, et al.
Published: (2023-12-01) -
Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only
by: Suvi Heinimäki, et al.
Published: (2020-07-01) -
Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses
by: Melika Haghighi, et al.
Published: (2022-05-01)